Khaitan, Debevoise, Platinum, JSA act on 3% acquisition by Capital International in Intas Pharma

PE Firm Capital International has bought 3% stake in Intas Pharmaceuticals from ChrysCapital , for an estimated value of ₹690 crore ($107 million).

ChrysCapital will continue to hold 3% in Intas.

Deal Capital International buys 3% stake in Intas Pharmaceuticals
With a premium account you get:
  • One year of unrestrcited access to previous interviews, columns and articles
  • One year access to all archival material
  • Access to all Bar & Bench reports